Research is exploring how communication and patient engagement can optimize treatment effectiveness and drive equitable health outcomes especially for aging and underserved populations.
Primary Researchers

Mariana Babayeva, PhD, MD
Area of interest includes the gender differences in renal excretion of organic cations and protein binding drug-drug interaction.

David Braverman, PharmD, RPh, BCSCP
Areas of interest include stability studies, disinfectant effectiveness testing and sterile compounding teaching methods a pedagogy.

Zvi Loewy, PhD
Areas of interest include clinical research focused on assessing the impact of pharmacogenomic testing on prescribing medications, and applied research that include stability studies and sterile compounding formulation, pharmacotherapy for COPD exacerbation evaluating novel chemical and biological antimicrobials and identifying and characterizing novel natural products with anti-biofilm activities.

Sidhartha D. Ray, PhD, FACN
Areas of interest include (i) Side effects of drugs, Drug-Drug & drug-phytochemical interactions. (ii) Antitoxic and Anticancer properties of phytochemicals in in vivo models; (iii) Role microRNA in drug-induced toxic reactions in in vivo models.